FDAnews Drug Daily Bulletin

PRE-LAUNCH INTERNET BUZZ FOR NEW DRUGS CAN LEAD TO GREATER ONLINE AWARENESS, NIELSEN BUZZMETRICS FINDS

May 3, 2006
A A

New drugs that create even small amounts of online discussion among consumers before they're approved by federal regulators often enjoy greater awareness and online "buzz" after they have been released to the market, according to an analysis by Nielsen BuzzMetrics. By tracking pre- and post-approval buzz of four new drugs, Nielsen BuzzMetrics' Healthcare Practice found that new drug therapies that generated even small amounts of pre-approval buzz enjoyed a comparatively large and sustained increase in discussion among relevant communities once the drugs were approved for use among the general population. Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=126469)